John Overdeck’s DermTech, Inc. Common Stock DMTK Stock Holding History

John Overdeck’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-53,391	Closed	-$93.4K	–	3472
2023 Q4	$93.4K	Buy	+53,391	New	+$78K	﹤0.01%	2944
2023 Q1	–	Sell	-139,341	Closed	-$247K	–	3277
2022 Q4	$247K	Sell	139,341 -18,577	-12%	-$49.4K	﹤0.01%	2320
2022 Q3	$625K	Sell	157,918 -251,626	-61%	-$1.55M	﹤0.01%	1672
2022 Q2	$2.27M	Buy	409,544 +262,934	+179%	+$2.15M	0.01%	1130
2022 Q1	$2.15M	Sell	146,610 -244,264	-62%	-$3.27M	0.01%	1319
2021 Q4	$6.18M	Buy	390,874 +164,419	+73%	+$3.95M	0.01%	1073
2021 Q3	$7.27M	Sell	226,455 -21,727	-9%	-$763K	0.02%	955
2021 Q2	$10.3M	Buy	+248,182	New	+$10.2M	0.02%	786
2020 Q4	–	Sell	-11,265	Closed	-$135K	–	3869
2020 Q3	$135K	Buy	+11,265	New	+$131K	﹤0.01%	2901

Other funds holding DMTK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WIC

Woodmont Investment Counsel Nashville, Tennessee $1.83B AUM 25.91% 1-Year Est. Return

John Overdeck's DMTK Position: Q1 2024 in Review

John Overdeck sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2024, closing a stake of 53,391 shares — an estimated $93.4K sold.

John Overdeck first reported a position in DMTK in Q3 2020 and held it in 9 quarters. The position peaked at $10.3M in Q2 2021. 69 funds tracked by Wall St. Rank hold DMTK as of Q1 2024.

John Overdeck reported no remaining DermTech, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
John Overdeck sold 53,391 DermTech, Inc. Common Stock shares in Q1 2024, an estimated $93.4K.
John Overdeck first reported a position in DermTech, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
John Overdeck's DermTech, Inc. Common Stock position peaked at $10.3M in Q2 2021.
69 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.